Lisata acquisition in limbo: Kuva Labs delays tender offer, seeks new financing

LISATA THERAPEUTICS, INC.

Kuva Labs has not yet commenced tender offer for Lisata; deadline extended from April 3 to April 13, 2026.
Kuva seeking alternative financing on more favorable terms; will launch tender only after financing finalized.
Lisata in discussions with Kuva regarding financing and timing; no assurance of commencement or deal completion.
Potential termination of Merger Agreement if tender not commenced; risks include termination fees and litigation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.